Evidence map›Paper›PMID 41855436›Full record

ArticleJCO global oncology2026

Artificial Intelligence-Based Diagnosis of Kaposi Sarcoma Using Digital Photographs in Dark-Skinned Patients in Uganda.

Sarah J Coates, Feng Yang, Cody Hill, Zhiyun Xue, Sivaramakrishnan Rajaraman, Aggrey Semeere, Racheal Ayanga, Miriam Laker-Oketta, Helen Byakwaga, Robert Lukande and 10 more

Abstract read
In one paragraph

Article in JCO global oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Sarah J CoatesDepartment of Dermatology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-9872-5602
Feng YangDivision of Imaging, Diagnostics, and Software Reliability, Office Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
Cody HillDivision of Intramural Research, National Library of Medicine, Bethesda, MD.
Zhiyun XueDivision of Intramural Research, National Library of Medicine, Bethesda, MD.
Sivaramakrishnan RajaramanDivision of Intramural Research, National Library of Medicine, Bethesda, MD.ORCID 0000-0003-0871-8634
Aggrey SemeereInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0003-1826-2239
Racheal AyangaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0002-6726-6300
Miriam Laker-OkettaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Helen ByakwagaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0002-4799-1564
Robert LukandePathology Department, Makerere University College of Health Sciences, Kampala, Uganda.
Matthew SemakaddeHIV Clinic, Masaka Regional Referral Hospital, Masaka, Uganda.
Micheal KanyesigyeImmune Suppression Syndrome Clinic, Mbarara Regional Referral Hospital, Mbarara, Uganda.
Megan WengerDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
Philip LeBoitDepartment of Pathology, University of California, San Francisco, San Francisco, CA.
Timothy McCalmontDepartment of Pathology, University of California, San Francisco, San Francisco, CA.
Ethel CesarmanDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.ORCID 0000-0003-3303-6299
David EricksonSibley School of Mechanical and Aerospace Engineering, Division of Nutritional Sciences, Cornell University, Ithaca, NY.ORCID 0000-0002-1624-9711
Toby MaurerDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN.
Sameer AntaniDivision of Intramural Research, National Library of Medicine, Bethesda, MD.ORCID 0000-0002-0040-1387
Jeffrey MartinDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-9773-3256

Funding

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related CancersU54CA254571 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARTIN, JEFFREY N · 2020 to 2025
$5.6M
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-DetectUH3CA202723 · NCI · CORNELL UNIVERSITY · PI ERICKSON, DAVID CARL, MARTIN, JEFFREY N · 2018 to 2021
$3.2M
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETEU01CA269199 · NCI · CORNELL UNIVERSITY · PI Ethel Cesarman, David Carl Erickson · 2022 to 2026
$3.0M
NCI NIH HHS U01 CA269199NCI NIH HHS U54 CA254571NCI NIH HHS UH3 CA202723
6 · The paper itself

Abstract

purposeThis study sought to evaluate the accuracy of artificial intelligence (AI)-based interpretation of digital surface images of skin lesions to diagnose Kaposi sarcoma (KS) among dark-skinned patients in Uganda.

methodsPatients were evaluated at skin biopsy services in Uganda because of clinical suspicion of KS. In a cross-sectional design, 482 consecutive participants were enrolled. Lesions were photographed using a digital camera, and punch biopsies were obtained. Histopathologic interpretation was considered the gold standard. Using training (approximately 70% of images) and validation (approximately 10% of images) sets, we developed a prediction model using a rule-based combination of You Only Look Once version 5 and 8 object detection classifiers. We determined sensitivity, specificity, and positive and negative predictive values of the AI-based prediction model in a test set (approximately 20% of images) and compared these with the accuracy of a dermatologist's visual interpretation of images.

resultsFour hundred seventy-two participants (1,385 images) were evaluable. Of these, 36% was female; the median age was 34 years; and 94% had HIV, 332 had KS, and 140 had no KS by histopathology. In the test set, the AI-derived prediction model achieved 89% sensitivity (85%-94%) and 51% specificity (40%-61%) for diagnosing KS; the positive predictive value was 81% (75%-86%), and the negative predictive value was 67% (55%-78%). The area under the receiver operating characteristic curve was 0.72. A dermatologist evaluating the same images, with emphasis on sensitivity, achieved a sensitivity of 93% (89%-96%) and a specificity of 19% (11%-28%).

conclusionAmong dark-skinned patients in Uganda with lesions suspicious for KS, evaluation of digital surface images by an AI-based prediction model produced moderate accuracy for diagnosing KS. While currently inadequate for clinical use, this inaugural assessment is sufficiently promising to justify future evaluation of larger data sets and evolving technologies.

Indexed as

Artificial IntelligencePhotographySarcoma, KaposiSkin NeoplasmsAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSensitivity and SpecificityUgandaYoung Adult

Identifiers

PMID41855436
PMCPMC13035104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.